Adverse drug reaction of carbamazepine on trigeminal neuralgia
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Poster
- By: OKAZAWA (Kanto Medical Center NTT EC, Pharmacy, Tokyo, Japan)
- Co-author(s): Doolin, Eiko Nakata (Kanto Medical Center NTT EC, TOKYO, Japan)
Orii (Kanto Medical Center NTT EC, Japan)
Objective: Reduction of adverse drug reaction of carbamazepine(CBZ) on trigeminal neuralgia by pharmacokinetics consideration.
Method used: We collected, tabulated, and analyze of data questionnaires and other sources.
Result: On trigeminal neuralgia CBZ dosage is determined by clinical practice without therapeutic drug monitoring (TDM) in.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.